08Jun 2024
Abbott Receives CE Mark for World's First Dual Chamber Leadless Pacemaker System

Abbott Receives CE Mark for World's First Dual Chamber Leadless Pacemaker System

Abbott received CE Mark approval for the AVEIR dual chamber (DR) leadless pacemaker system, the world's first to treat abnormal heart rhythms with beat-to-beat wireless communication. This innovation, featuring two small devices for right ventricle and atrium pacing, eliminates the need for cardiac leads, reducing complications and recovery time. AVEIR DR's synchronized pacing technology, based on Abbott's i2i communication, significantly enhances patient care. The system met primary safety and efficacy endpoints in clinical studies and gained US FDA approval in June 2023.

  • #family health

Like

Save

Share